镰状细胞病的今天：从 "第一种分子疾病 "到 "第一种基因编辑疗法 "的 75 年历程。

IF 2.1 4区医学 Q2 MEDICINE, GENERAL & INTERNAL

Swiss medical weekly Pub Date : 2024-04-10 DOI:10.57187/s.3829

Marc Schapira, Mark J. Koury, Irene Roberts

引用次数: 0

摘要

无摘要。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Sickle cell disease today: a 75-year journey from "first molecular disease" to "first gene-editing therapy".

No abstract available.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Swiss medical weekly 医学-医学：内科

CiteScore

5.00

自引率

0.00%

发文量

审稿时长

3-8 weeks

期刊介绍： The Swiss Medical Weekly accepts for consideration original and review articles from all fields of medicine. The quality of SMW publications is guaranteed by a consistent policy of rigorous single-blind peer review. All editorial decisions are made by research-active academics.